IN A RECENT ISSUE OF THE Journal, Londino et al. (15) report that the influenza matrix protein M2 decreases the activity of the human cystic fibrosis transmembrane conductance regulator (CFTR) by increasing secretory organelle pH, which results in downregulation of CFTR in a ubiquitination-dependent manner.
Influenza infects about 10 -16% of the US population annually, often leading to hospitalizations and up to 50,000 influenza-associated deaths (28) . Those numbers are bound to rise even more in the face of an epidemic, especially with the aging population (18) . Severe influenza infections and fatal outcome typically occur in the elderly, immunocompromised patients, and patients with chronic diseases. For example, influenza and other respiratory viral infections are responsible for one-third of pulmonary exacerbations in patients with cystic fibrosis (CF) (8) .
CF, an autosomal recessive disorder, is the most common human monogenetic fatal disease, affecting ϳ1 in 3,000 live births (5) . It is caused by mutations of the cftr gene, resulting in loss of function of the CFTR channel, the primary anion transporter of the human lung epithelium regulating transport of Cl Ϫ ions, by altering protein folding, trafficking and channel gating in epithelial cells (31) . CFTR is located in the apical membrane of secretory and absorptive epithelial cells (24) and functions primarily as a cAMP-regulated Cl Ϫ channel but also affects bicarbonate, sodium, and water transport (21, 23) . As part of the ATP binding cassette (ABC) family, CFTR consists of two homologous cytoplasmatic nucleotide-binding domains and two membrane-spanning domains. After synthesis in the endoplasmic reticulum (ER) CFTR undergoes a multistep glycosylation and folding process before being trafficked to the plasma membrane. This process is subject to a tight quality control as more than 50% of the wild-type CFTR proteins end up being misfolded (30) . The misfolded CFTR are subsequently being targeted for ubiquitination (2) with the carboxy terminus of Hsp70-interacting protein (CHIP) being implicated as a potential E3 ligase for CFTR. Interestingly, another E3 ligase, the neural precursor cell expressed developmentally downregulated protein 4-2 (NEDD4-2), ubiquitinates one of the most common CFTR mutant ⌬F508 but apparently does not regulate wild-type CFTR in human airway epithelial cells (9) . The impairment of CFTR functions in patients with CF results in elevated sweat chloride, pancreatic insufficiency, recurrent lung infections, and bronchiectasis, ultimately leading to death by respiratory failure (24) .
The epithelial cells of the airway are the first targets for the influenza virus, eliciting an immune response leading to activation of a myriad of signaling pathways, ultimately resulting in apoptosis of the host cell (27) . The majority of influenza infections are caused by influenza virus A, which consists of three transmembrane proteins: hemagglutinin, neuraminidase, and matrix protein 2 (M2). The M2 protein is a homotetramer that functions as a proton channel. M2 is the prototype for a class of viral ion channels known as viroporins and is targeted by the anti-influenza drugs amantadine and rimantadine. M2 facilitates diffusion of protons into the endosome, thereby aiding with the uncoating of the viral RNA form the M1 protein (1) .
The amount and composition of the epithelial lining fluid (ELF) is regulated by ion transporters (16) . Several excellent recent publications focused on the crucial role of CFTR in the regulation of alveolar fluid balance and its interplay with ENaC and other ion channels and transporters in vitro and in vivo (3, 4, 6, 10, (12) (13) (14) . In addition to being a key regulator of ELF, there is growing evidence that CFTR plays a role in modifying immune response (7) .
The present study of Londino and colleagues (15) investigated the regulation of CFTR by influenza virus and conclusively demonstrated that the M2 protein of influenza A impairs CFTR function by decreasing its activity and expression ( Fig. 1) . The study focused on the interaction of M2 protein with CFTR, because M2 forms a proton channel and is known to alkalinize organelles of the secretory pathway, thereby interfering with protein trafficking (26) . Furthermore, CFTR has been shown to be responsive to changes in vesicular pH (19) . The authors applied various in vitro model systems to investigate the interaction between M2 and CFTR such as Xenopus laevis oocytes injected with human cDNA, human embryonic kidney cells (HEK-293) stably transfected with CFTR and a human bronchial epithelial cell line (16HBE14oϪ) expressing endogenous CFTR. In Xenopus oocytes M2 inhibited CFTR activity in a dose-dependent manner by suppressing the expression of the mature, fully glycosylated form of CFTR but not the expression of total amount of CFTR, therefore implicating posttranslational modification of CFTR as the mechanism. These effects were M2 specific, since coinjection with influenza matrix protein M1 affected neither CFTR activity nor expression, therefore excluding the possibility that the effects on CFTR were solely due to the influence of the influenza virus on protein synthesis in general. Furthermore, M2 did not inhibit overall protein trafficking since M2 did not affect the calcium channel transient receptor potential vanilloid 5. Londino et al. further showed that, unlike the regulation of ENaC (11), the actions of M2 on CFTR were not dependent on reactive oxygen species. The proton channel activity of M2 was required for inhibition of CFTR as incubation with the anti-influenza drug amantadine (specifically targeting the proton channel portion of M2) rescued CFTR function and expression in oocytes expressing both M2 and CFTR. However, in oocytes solely expressing CFTR amantadine had no effects. To further determine the role of the proton channel function of M2, the authors utilized the M2 mutants M2-G34V and M2-V27F, in which the proton channel portion of M2 is defective (1). When CFTR was coexpressed with M2-G34V there was no change in the GlyH-101-sensitive current (indicating CFTR specificity) compared with negative controls. Interestingly, coexpression with M2-V27F resulted only in minor alteration of CFTR activity compared with M2-G34V, although both constructs displayed equal levels of expression and trafficking to the plasma membrane. Moreover, it was demonstrated that, unlike CFTR, inhibition of ENaC was independent from the proton channel activity of M2. In oocytes injected with ␣/␤/ ␥-ENaC and M2-G34V mutant, the activity of ENaC was suppressed comparable to wild-type M2. Further evidence that the ability of M2 to inhibit CFTR activity was mediated through alkalinization of organelles though proton transport was supported by the fact that oocytes incubated with agents increasing the pH in acidified organelles suppressed CFTR activity. Londino et al. hypothesized that, for M2 to alkalize organelles of the secretory pathway, it needed to traffic past the ER to suppress CFTR activity. Therefore they utilized a M2 mutant (M2-ER) known to be retained in the ER (26) . In oocytes coinjected with CFTR and M2-ER, mature, glycosylated levels of CFTR were equal compared with control oocytes and therefore did not display any impairment of CFTR activity. The decrease in mature CFTR in the plasma membrane with M2 incubation suggests an alteration of CFTR maturation or degradation by M2 as the underlying mechanism for the suppressed CFTR activity. Administration of PYR-41, an inhibitor of E1 ubiquitin activating enzyme, partially rescued CFTR activity in oocytes coexpressing M2 and CFTR, indicating that ubiquitination may play a role in the M2-dependent downregulation of CFTR.
To confirm the biological relevance of their findings in mammalian systems, the authors performed additional experiments in HEK-293 and 16HBE14oϪ cells. In both HEK-293 cells stably expressing CFTR and bronchial 16HBE14oϪ cells influenza M2 decreased CFTR activity and expression. In addition to providing data at the level of protein expression and elaborate electrophysiological measurements, the use of various systems is one of the major strengths of the study since the different model systems are complementary to each other. The use of Xenopus oocytes, as one of the premier systems for electrophysiological measurements, yields quantifiable, unambiguous data, and HEK-293 and 16HBE14oϪ convincingly demonstrate the relevance of the findings in mammalian systems.
The findings of Londino et al. (15) are novel and clinically relevant, since changes in CFTR activity during influenza infection may impact both alveolar fluid balance and the immune response, thereby contributing to lung injury. Of special significance will be the role of ubiquitination, which has already been shown to play a role in the regulation of alveolar fluid clearance (29) . Further studies elucidating the regulation of ubiquitination of CFTR in the setting of influenza infections will be of particular interest, since better insight of these mechanisms may promote innovative therapies targeting elements of the ubiquitination pathway. Indeed, several exciting novel drugs target dysfunctional CFTR proteins. These include so called potentiators that enhance channel gating and correctors that either directly bind to the mutant CFTR, thereby preventing recognition of the altered protein by the cellular protein quality control systems or modulate quality control itself, thus enhancing stability and trafficking of the channel to the plasma membrane (24) .
The studies of Londino and colleagues provide an excellent base for further studies elucidating the effects of interactions between the M2 influenza protein and CFTR on epithelial function, especially the composition and amount of ELF, in the setting of lung injury. Also, given that CFTR has been implicated in the regulation of ENaC and vice versa (3, 12, 14, 17, 22, 25) and M2 downregulates both channels [by apparently different mechanisms (11, 15) ], it will be interesting to see whether M2 also alters the interplay of the two transporters in the distal lung epithelium. Moreover, since CFTR has been shown to be differentially expressed in distinct cells types and locations of the airway (3) it will be crucial to test whether these in vitro findings will hold up in vivo systems, to gauge the translational importance of the M2-CFTR interaction.
The present study convincingly demonstrated that the M2 protein impaired CFTR to function as a Cl Ϫ transporter. It would be of interest to investigate whether the influenza virus or the M2 protein particularly also alters other functions of CFTR, for example the bicarbonate transport activity of the channel. Such studies might be of high clinical relevance since compacted, poorly transportable mucus serves as a "seed-bed" of recurrent pulmonary infections in patients with CF and dysfunctional CFTR causes a bicarbonate-poor milieu in the airways, thereby impairing unfolding and expansion of mucus (20) . Another avenue not yet explored, but, in light of the increased risks that influenza infection poses for patients with CF, clinically highly relevant, would be the effect of M2 protein on already dysfunctional CFTR.
In summary, the findings by Londino et al. (15) provide novel insights into a previously undescribed role of the influenza A M2 protein in the regulation of CFTR, which may lead to novel therapeutic strategies in the management of lung injury in the setting of influenza infection. 
